Nanovibronix, Inc. (NASDAQ:FEED) Short Interest Up 546.8% in June

Nanovibronix, Inc. (NASDAQ:FEED) was the recipient of a significant increase in short interest in June. As of June 15th, there was short interest totaling 409,683 shares, an increase of 546.8% from the May 31st total of 63,342 shares. Currently, 6.8% of the shares of the stock are sold short. Based on an average daily trading volume, of 2,865,952 shares, the short-interest ratio is currently 0.1 days.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Wall Street Zen raised Nanovibronix from a “strong sell” rating to a “sell” rating in a report on Tuesday, April 28th. Weiss Ratings reissued a “sell (e+)” rating on shares of Nanovibronix in a research note on Friday, April 24th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.

Insiders Place Their Bets

In other Nanovibronix news, insider Christian Michael Glibert sold 210,000 shares of the stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $0.69, for a total value of $144,900.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.40% of the company’s stock.

Nanovibronix Stock Up 1.3%

FEED stock traded up $0.01 during trading on Friday, reaching $0.58. 81,330 shares of the stock were exchanged, compared to its average volume of 1,775,685. The stock has a 50 day simple moving average of $1.01. Nanovibronix has a 1 year low of $0.55 and a 1 year high of $17.40. The stock has a market cap of $3.51 million, a price-to-earnings ratio of -0.07 and a beta of 1.51.

Nanovibronix (NASDAQ:FEED) last posted its earnings results on Monday, May 18th. The company reported ($6.88) earnings per share for the quarter. The firm had revenue of $0.65 million during the quarter. Nanovibronix had a negative net margin of 923.20% and a negative return on equity of 54.25%.

About Nanovibronix

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.